The U.S. Food and Drug Administration is in the midst of hearings to assess how to regulate homeopathic medicine and practice for the first time in a quarter-century.
More than half a dozen proponents of homeopathy - which is based on the belief that disease symptoms can be cured by minute doses of a remedy that would, in larger amounts, produce in healthy persons symptoms similar to the disease - are testifying before the FDA, along with skeptics who think such remedies should be subjected to the same scrutiny as over-the-counter drugs.
Would that mean homeopathy would be subjected to clinical trials? How should labeling change? Is enough known about the side effects of homeopathic products?
Michael De Dora, director of the Center for Inquiry's Office of Public Policy; a non-profit organization advocating for science-based policy; De Dora provided testimony to the FDA hearings on homeopathy oversight
Paul Herscu, ND & MPH, Licensed Naturopathic Physician and published author who writes frequently on issues in homeopathy